APA (7th ed.) Citation

S, D., S, F., V, K., S, I., & A, C. (2026). A sstR2-targeted radiohybrid theranostic agent for PET imaging and β- therapy with excellent preclinical performance. Npj imaging, 4(1), . https://doi.org/10.1038/s44303-026-00155-w

Chicago Style (17th ed.) Citation

S, Deiser, Fenzl S, König V, Inoue S, and Casini A. "A SstR2-targeted Radiohybrid Theranostic Agent for PET Imaging and β- Therapy with Excellent Preclinical Performance." Npj Imaging 4, no. 1 (2026). https://doi.org/10.1038/s44303-026-00155-w.

MLA (9th ed.) Citation

S, Deiser, et al. "A SstR2-targeted Radiohybrid Theranostic Agent for PET Imaging and β- Therapy with Excellent Preclinical Performance." Npj Imaging, vol. 4, no. 1, 2026, https://doi.org/10.1038/s44303-026-00155-w.